Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.

MLA

Jiang, Di Maria, et al. “Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.” Clinical Colorectal Cancer, vol. 22, no. 4, Dec. 2023, pp. 457–63. EBSCOhost, https://doi.org/10.1016/j.clcc.2023.08.006.

APA

Jiang, D. M., Parshad, S., Zhan, L., Sim, H.-W., Siu, L. L., Liu, G., Shapiro, J. D., Price, T. J., Jonker, D. J., Karapetis, C. S., Strickland, A. H., Zhang, W., Jeffery, M., Tu, D., Ng, S., Sabesan, S., Shannon, J., Townsend, A., O’Callaghan, C. J., & Chen, E. X. (2023). Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. Clinical Colorectal Cancer, 22(4), 457–463. https://doi.org/10.1016/j.clcc.2023.08.006

Chicago

Jiang, Di Maria, Shruti Parshad, Luna Zhan, Hao-Wen Sim, Lillian L Siu, Geoffrey Liu, Jeremy D Shapiro, et al. 2023. “Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.” Clinical Colorectal Cancer 22 (4): 457–63. doi:10.1016/j.clcc.2023.08.006.